Outcomes of Patients With Inflammatory Bowel Diseases Switched from Maintenance Therapy with a Biosimilar to Remicade.

QR kód

Outcomes of Patients With Inflammatory Bowel Diseases Switched from Maintenance Therapy with a Biosimilar to Remicade.

There is evidence that it is safe and effective for patients with inflammatory bowel diseases (IBD) to switch from maintenance therapy with an original infliximab drug to a biosimilar, but little is known about outcomes of reverse switches and/or multiple switches. We aimed to evaluate the effects o...

Teljes leírás

Elmentve itt :

Bibliográfiai részletek
Szerzők:	Iliás Ákos Szántó Kata Gönczi Lóránt Kürti Zsuzsanna Golovics Petra Anna Farkas Klaudia Szepes Zoltán Szalay Balázs Vincze Áron Molnár Tamás Lakatos Péter László
Dokumentumtípus:	Cikk
Megjelent:	2019
Sorozat:	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 17 No. 12
doi:	10.1016/j.cgh.2018.12.036
mtmt:	30388151
Online Access:	http://publicatio.bibl.u-szeged.hu/15467

Hasonló tételek

Switching from infliximab to biosimilar in inflammatory bowel disease
Szerző: Milassin Ágnes, et al.
Megjelent: (2019)

Non-medical switch from the originator to biosimilar and between biosimilars of adalimumab in inflammatory bowel disease – a prospective, multicentre study
Szerző: Lontai Livia, et al.
Megjelent: (2022)

Self-reported efficacy and safety of infliximab and adalimumab biosimilars after non-medical switch in patients with inflammatory bowel disease results of a multicenter survey /
Szerző: Sarlós Patrícia, et al.
Megjelent: (2023)

A review on biosimilar infliximab, CT-P13, in the treatment of inflammatory bowel disease
Szerző: Farkas Klaudia, et al.
Megjelent: (2018)

Efficacy, Safety, and Cost-Effectiveness of the Infliximab Biosimilar GP-1111 in Patients with Inflammatory Bowel Disease Who Underwent a Nonmedical Switch A Prospective Cohort Study /
Szerző: Pápista Máté, et al.
Megjelent: (2025)

Efficacy and safety of the biosimilar infliximab CT-P13 treatment in inflammatory bowel diseases a prospective; multicentre; nationwide cohort /
Szerző: Gecse Krisztina Barbara, et al.
Megjelent: (2016)

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases results from Central European nationwide cohort /
Szerző: Bálint Anita, et al.
Megjelent: (2017)

Outcome of immediate dose optimization of infliximab in inflammatory bowel disease patients
Szerző: Bacsur Péter, et al.
Megjelent: (2022)

Outcomes of treatment cessation afterswitching to subcutaneous vedolizumab treatment in inflammatory bowel diseases
Szerző: Bacsur Péter, et al.
Megjelent: (2024)

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases
Szerző: Gönczi Lóránt, et al.
Megjelent: (2017)

Sarcopenia as an independent predictor of the surgical outcomes of patients with inflammatory bowel disease
Szerző: Erős Adrienn, et al.
Megjelent: (2020)

Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy
Szerző: Bálint Anita, et al.
Megjelent: (2015)

Post-inflammatory polyps burden as a prognostic marker of disease-outcome in patients with inflammatory bowel disease
Szerző: Ellul Pierre, et al.
Megjelent: (2023)

Diagnosis and outcome of extranodal primary intestinal lymphoma in inflammatory bowel disease An ECCO CONFER Case Series /
Szerző: Phillips Frank, et al.
Megjelent: (2022)

New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents Cyclosporine Plus Vedolizumab /
Szerző: Szántó Kata Judit, et al.
Megjelent: (2018)

Co-Administration of Proton Pump Inhibitors May Negatively Affect the Outcome in Inflammatory Bowel Disease Treated with Vedolizumab
Szerző: Szemes Kata, et al.
Megjelent: (2024)

How do you like the pen? Patients' opinion about switching adalimumab from prefilled syringe to pen in inflammatory bowel disease
Szerző: Szántó Kata, et al.
Megjelent: (2018)

Lupus-like reactions in patients with inflammatory bowel disease
Szerző: Pigniczki Daniella, et al.
Megjelent: (2019)

Higher Vedolizumab Clearance Associates with Poor Therapeutic Outcomes during Intravenous Vedolizumab Maintenance Therapy in Crohn's Disease
Szerző: Anjie Suzanne I, et al.
Megjelent: (2026)

Iron Deficiency Anemia in Inflammatory Bowel Disease What Do We Know? /
Szerző: Resál Tamás, et al.
Megjelent: (2021)

Steroid but not biological therapy elevates the risk of venous thromboembolic events in inflammatory bowel disease a meta-analysis /
Szerző: Sarlós Patrícia, et al.
Megjelent: (2018)

ECCO Guidelines on Inflammatory Bowel Disease and Malignancies
Szerző: Gordon Hannah, et al.
Megjelent: (2023)

Evaluation of dysplasias associated with inflammatory bowel disease
Szerző: Balajthy Zsófia
Megjelent: (2026)

Effects of bowel cleansing on the composition of the gut microbiota in inflammatory bowel disease patients and healthy controls
Szerző: Bacsur Péter, et al.
Megjelent: (2023)

Inflammatory Bowel Disease-Mimicking Colitis Associated With Nintedanib-Based Therapy in a Lung Cancer Patient
Szerző: Sejben Anita, et al.
Megjelent: (2023)

Efficacy of infliximab biosimilar CT-P13 induction therapy on mucosal healing in ulcerative colitis
Szerző: Farkas Klaudia, et al.
Megjelent: (2016)

Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease long-term extension data from a Phase 3 study /
Szerző: Schmidt Christoph, et al.
Megjelent: (2016)

Importance of Diet in Inflammatory Bowel Disease – Data from the Patients’ View
Szerző: Molnár Tamás, et al.
Megjelent: (2014)

Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
Szerző: Mandel Michael D., et al.
Megjelent: (2014)

Tuberculin skin test and Quantiferon in BCG vaccinated; immunosuppressed patients with moderate-to-severe inflammatory bowel disease
Szerző: Kürti Zsuzsanna, et al.
Megjelent: (2015)

Spotlight on Transition in Patients With Inflammatory Bowel Disease A Systematic Review /
Szerző: Erős Adrienn, et al.
Megjelent: (2020)

Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis
Szerző: Farkas Klaudia, et al.
Megjelent: (2014)

The Role of Physical Activity and Physiotherapists in the Management of Inflammatory Bowel Disease A Nationwide Cross-Sectional Survey /
Szerző: Kovács Zita, et al.
Megjelent: (2026)

The Role of Gut Permeability and Serine-Proteases in the Pathomechanism of Irritable Bowel Syndrome and Inflammatory Bowel Diseases
Szerző: Gecse Krisztina
Megjelent: (2012)

Surgery Due to Inflammatory Bowel Disease During Pregnancy Mothers and Offspring Outcomes From an Ecco Confer Multicentre Case Series (Scar Study) /
Szerző: Chaparro María, et al.
Megjelent: (2022)

Inflammatory Bowel Disease and Physical activity a study on the impact of diagnosis on the level of exercise amongst patients with IBD /
Szerző: Gatt K., et al.
Megjelent: (2019)

Biological therapy and surgery rates in inflammatory bowel diseases - Data analysis of almost 1000 patients from a Hungarian tertiary IBD center
Szerző: Szántó Kata, et al.
Megjelent: (2018)

Maintenance systems
Szerző: Dumitrescu Constantin Dan, et al.
Megjelent: (2020)

Adverse events associated with management of inflammatory bowel diseases infections and side effects /
Szerző: Bálint Anita
Megjelent: (2015)

Does inflammatory bowel disease have different characteristics according to stage of adolescence?
Szerző: Szántó Kata Judit, et al.
Megjelent: (2021)